by Catherine Lee | Sep 24, 2026 | ADD, ADHD, Attention Deficit Hyperactivity Disorder, Dyslexia, Menopause, Neurodiversity, Neurodiversity at Work, Psychosocial hazards, Women's health, Workplace Health and Safety
She has been good at her job for years. Not just adequate. Really good. Experienced, reliable, knowledgeable. The person others turn to when something complicated needs sorting out. Then something changes. She is exhausted. Her concentration is less reliable. She...
by Catherine Lee | Feb 19, 2026 | ADD, ADHD, Attention Deficit Hyperactivity Disorder, Autism, Diversity, Dyslexia, Equity and Inclusion, Neurodiversity, Neurodiversity Awareness Training, Psychosocial hazards, Uncategorized, Workplace Health and Safety
Neurodiversity Celebration Week (16–20 March 2026) Encourages organisations to recognise neurological difference as part of the natural human variation. That recognition matters. But recognition without reform risks becoming symbolic or performative. In my coaching...
by Catherine Lee | Dec 3, 2025 | ADD, ADHD, Attention Deficit Hyperactivity Disorder, Diversity, Equity and Inclusion, Neurodiversity, Neurodiversity Awareness Training, Psychosocial hazards, Workplace Health and Safety
When the Elephant Finally Moves Why Neurodiversity Must Shape How We Understand Risk at Work In my article “Psychosocial Risk and Neurodiversity: The Elephant in the Room” published on LinkedIn on 7 November, I explained why neurodiversity must be at the heart of...
by Catherine Lee | Sep 25, 2025 | ADD, ADHD, Attention Deficit Hyperactivity Disorder, Autism, Diversity, Equity and Inclusion, Neurodiversity
The United States (US) White House made headlines on 23 September 2025 with a statement that it had achieved “major progress in understanding the root causes of autism.” The announcement pointed the finger at acetaminophen (commonly known as Panadol or Tylenol) during...
